Showing 20 of 86 recruiting trials for “squamous-cell-carcinoma-of-the-nasal-cavity-and-paranasal-sinuses”
RecruitingNCT05858385 ↗
Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
🏥 Affiliated Cancer Hospital & Institute of Guangzhou Medical University📍 1 site📅 Started Sep 2022View details ↗
SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
Optimization of Cervical Nodal CTV for Early and Medium Stage NPC
RecruitingNCT05707819 ↗
Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
👨⚕️ Xiao-Dong Zhu, Doctor, Cancer Hospital of Guangxi Medical University📍 1 site📅 Started Jul 2022View details ↗
Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal Carcinoma
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma
Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer
Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy
RecruitingNCT05126160 ↗
Immune Score Based Radiomics in Nasopharyngeal Carcinoma
👨⚕️ Xiaozhong Chen, Department of Radiation Oncology, Zhejiang Cancer Hospital📍 5 sites📅 Started Nov 2021View details ↗
ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma
Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
👨⚕️ Jinquan Liu, M.D, Affiliated Cancer Hospital & Institute of Guangzhou Medical University📍 1 site📅 Started Aug 2020View details ↗
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →